$RGEN
REPLIGEN CORP

2019 Q2 Form 10-Q Financial Statement

#000119312519142798 Filed on May 09, 2019

View on sec.gov

Income Statement

Concept 2019 Q2 2019 Q1 2018 Q4
Revenue $70.70M $60.63M $51.94M
YoY Change 48.12% 35.25% 24.83%
Cost Of Revenue $30.70M $26.85M $23.60M
YoY Change 45.58% 36.49% 23.33%
Gross Profit $40.00M $33.79M $28.35M
YoY Change 50.13% 34.29% 26.14%
Gross Profit Margin 56.58% 55.73% 54.58%
Selling, General & Admin $15.80M $19.00M $14.70M
YoY Change -4.76% 19.5% -8.94%
% of Gross Profit 39.5% 56.23% 51.85%
Research & Development $5.200M $3.620M $3.200M
YoY Change -10.03% 10.1% 4.27%
% of Gross Profit 13.0% 10.71% 11.29%
Depreciation & Amortization $4.840M $1.600M $4.000M
YoY Change 23.16% 23.08% -3.38%
% of Gross Profit 12.1% 4.74% 14.11%
Operating Expenses $24.10M $22.62M $44.09M
YoY Change -44.54% -41.79% 14.97%
Operating Profit $15.90M $11.17M -$15.74M
YoY Change 272.1% 86.93% -582.5%
Interest Expense -$700.0K $1.726M -$1.100M
YoY Change -141.94% 4.48% -167.2%
% of Operating Profit -4.4% 15.45%
Other Income/Expense, Net -$700.0K -$655.0K $100.0K
YoY Change -378.88% -53.21% -171.94%
Pretax Income $9.600M $10.52M $6.900M
YoY Change 185.12% 129.81% 345.45%
Income Tax $1.500M $2.463M $1.200M
% Of Pretax Income 15.63% 23.42% 17.39%
Net Earnings $8.100M $8.053M $5.638M
YoY Change 195.84% 133.56% -53.7%
Net Earnings / Revenue 11.46% 13.28% 10.85%
Basic Earnings Per Share $0.18 $0.13
Diluted Earnings Per Share $165.0K $0.17 $0.12
COMMON SHARES
Basic Shares Outstanding 47.23M 43.97K 43.86M shares
Diluted Shares Outstanding 46.28K

Balance Sheet

Concept 2019 Q2 2019 Q1 2018 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $208.9M $196.1M $193.8M
YoY Change 18.96% 12.77% 11.51%
Cash & Equivalents $208.9M $196.1M $193.8M
Short-Term Investments
Other Short-Term Assets $12.80M $3.700M $697.0K
YoY Change 178.26% -24.49% 219.72%
Inventory $51.30M $44.92M $42.26M
Prepaid Expenses
Receivables $43.00M $39.34M $33.02M
Other Receivables $500.0K $100.0K $2.800M
Total Short-Term Assets $316.5M $284.1M $275.7M
YoY Change 25.14% 14.4% 13.57%
LONG-TERM ASSETS
Property, Plant & Equipment $57.60M $34.53M $32.18M
YoY Change 140.07% 52.27% 43.55%
Goodwill $326.4M $326.7M
YoY Change -0.49% -0.18%
Intangibles $132.6M $135.4M
YoY Change -6.77% -6.44%
Long-Term Investments
YoY Change
Other Assets $4.200M $173.0K $174.0K
YoY Change 120.82% -91.31% -97.21%
Total Long-Term Assets $751.8M $513.8M $498.9M
YoY Change 52.75% 3.82% -0.37%
TOTAL ASSETS
Total Short-Term Assets $316.5M $284.1M $275.7M
Total Long-Term Assets $751.8M $513.8M $498.9M
Total Assets $1.068B $797.9M $774.6M
YoY Change 43.38% 7.36% 4.18%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $11.30M $9.823M $10.49M
YoY Change 68.96% 58.44% 44.04%
Accrued Expenses $17.80M $12.76M $15.87M
YoY Change 35.86% -9.64% -11.51%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $105.7M $104.6M $103.5M
YoY Change 4.34%
Total Short-Term Liabilities $140.9M $130.3M $129.8M
YoY Change 16.33% 541.1% 415.02%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0% -100.0%
Other Long-Term Liabilities $20.70M $433.0K $4.125M
YoY Change 344.21% -90.61% 76.06%
Total Long-Term Liabilities $20.70M $433.0K $4.125M
YoY Change 344.21% -90.61% 76.06%
TOTAL LIABILITIES
Total Short-Term Liabilities $140.9M $130.3M $129.8M
Total Long-Term Liabilities $20.70M $433.0K $4.125M
Total Liabilities $189.3M $172.9M $159.1M
YoY Change 50.5% 593.5% 4.66%
SHAREHOLDERS EQUITY
Retained Earnings -$7.515M -$15.57M
YoY Change -73.85% -50.59%
Common Stock $646.3M $643.0M
YoY Change 2.26% 2.16%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $879.0M $625.0M $615.6M
YoY Change
Total Liabilities & Shareholders Equity $1.068B $797.9M $774.6M
YoY Change 43.38% 7.36% 4.18%

Cashflow Statement

Concept 2019 Q2 2019 Q1 2018 Q4
OPERATING ACTIVITIES
Net Income $8.100M $8.053M $5.638M
YoY Change 195.84% 133.56% -53.7%
Depreciation, Depletion And Amortization $4.840M $1.600M $4.000M
YoY Change 23.16% 23.08% -3.38%
Cash From Operating Activities $17.79M $9.788M $5.550M
YoY Change 197.99% 522.65% -63.53%
INVESTING ACTIVITIES
Capital Expenditures -$5.300M $2.088M -$4.200M
YoY Change 85.96% 33.5% 138.64%
Acquisitions
YoY Change
Other Investing Activities -$182.2M -$1.260M
YoY Change -940.0%
Cash From Investing Activities -$187.5M -$3.828M -$5.460M
YoY Change 6478.25% 144.76% 237.04%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $189.6M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 190.1M 44.00K 1.050M
YoY Change 16433.04% -86.79% 238.71%
NET CHANGE
Cash From Operating Activities 17.79M 9.788M 5.550M
Cash From Investing Activities -187.5M -3.828M -5.460M
Cash From Financing Activities 190.1M 44.00K 1.050M
Net Change In Cash 20.44M 6.004M 1.140M
YoY Change 378.69% 1660.7% -91.8%
FREE CASH FLOW
Cash From Operating Activities $17.79M $9.788M $5.550M
Capital Expenditures -$5.300M $2.088M -$4.200M
Free Cash Flow $23.09M $7.700M $9.750M
YoY Change 161.79% 96150.0% -42.58%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2019Q1 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
34526000
CY2018Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
32180000
CY2019Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
132648000
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
135438000
CY2019Q1 us-gaap Goodwill
Goodwill
326395000
CY2018Q4 us-gaap Goodwill
Goodwill
326735000
CY2019Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
196135000
CY2018Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
193822000
CY2019Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
39341000
CY2018Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
33015000
CY2019Q1 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
173000
CY2019Q1 us-gaap Assets
Assets
797921000
CY2018Q4 us-gaap Assets
Assets
774621000
CY2018Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
174000
CY2019Q1 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
21000
CY2018Q4 us-gaap Other Receivables Gross Current
OtherReceivablesGrossCurrent
136000
CY2019Q1 us-gaap Inventory Net
InventoryNet
44920000
CY2018Q4 us-gaap Inventory Net
InventoryNet
42263000
CY2019Q1 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3660000
CY2018Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
3901000
CY2019Q1 us-gaap Assets Current
AssetsCurrent
284077000
CY2018Q4 us-gaap Assets Current
AssetsCurrent
275739000
CY2019Q1 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
25097000
CY2018Q4 us-gaap Deferred Tax Liabilities Noncurrent
DeferredTaxLiabilitiesNoncurrent
25086000
CY2019Q1 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
433000
CY2018Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
4125000
CY2019Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2018Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
797921000
CY2018Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
774621000
CY2019Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
9823000
CY2018Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
10489000
CY2019Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
12760000
CY2018Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
15865000
CY2019Q1 us-gaap Liabilities Current
LiabilitiesCurrent
130278000
CY2018Q4 us-gaap Liabilities Current
LiabilitiesCurrent
129842000
CY2019Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2019Q1 us-gaap Common Stock Value
CommonStockValue
441000
CY2018Q4 us-gaap Common Stock Value
CommonStockValue
439000
CY2019Q1 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
645883000
CY2018Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
642590000
CY2019Q1 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-13784000
CY2018Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-11893000
CY2019Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-7515000
CY2018Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-15568000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
625025000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
615568000
CY2019Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
26845000
CY2018Q1 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
19668000
CY2019Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3620000
CY2018Q1 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
3288000
CY2019Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.18
CY2019Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.17
CY2019Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
18998000
CY2019Q1 us-gaap Costs And Expenses
CostsAndExpenses
49463000
CY2018Q1 us-gaap Costs And Expenses
CostsAndExpenses
38854000
CY2018Q1 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
15898000
CY2018Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
345000
CY2019Q1 us-gaap Stockholders Equity
StockholdersEquity
625025000
CY2018Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.08
CY2018Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.08
CY2018Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
2268000
CY2017Q4 us-gaap Stockholders Equity
StockholdersEquity
591548000
CY2019Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
11171000
CY2018Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
5976000
CY2019Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-1891000
CY2018Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
251000
CY2019Q1 us-gaap Investment Income Net
InvestmentIncomeNet
713000
CY2018Q1 us-gaap Investment Income Net
InvestmentIncomeNet
181000
CY2019Q1 us-gaap Interest Expense
InterestExpense
1726000
CY2018Q1 us-gaap Interest Expense
InterestExpense
1652000
CY2019Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
358000
CY2018Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
71000
CY2019Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
10516000
CY2018Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
4576000
CY2019Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
2463000
CY2018Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1128000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
8053000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
3448000
CY2018Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43621
CY2018Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44327
CY2019Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
6162000
CY2018Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
3699000
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43968
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46279
CY2019Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3251000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
615568000
CY2019Q1 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
44000
CY2018Q1 us-gaap Stockholders Equity
StockholdersEquity
597183000
CY2019Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
4213000
CY2018Q1 us-gaap Depreciation And Amortization
DepreciationAndAmortization
3960000
CY2019Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1107000
CY2018Q1 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1036000
CY2019Q1 us-gaap Share Based Compensation
ShareBasedCompensation
3251000
CY2018Q1 us-gaap Share Based Compensation
ShareBasedCompensation
2268000
CY2019Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
892000
CY2018Q1 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
449000
CY2019Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
6692000
CY2018Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
1529000
CY2019Q1 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-112000
CY2018Q1 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-127000
CY2019Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1478000
CY2018Q1 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
1188000
CY2019Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-215000
CY2018Q1 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
1608000
CY2019Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-570000
CY2018Q1 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1550000
CY2019Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-1855000
CY2018Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
-3839000
CY2019Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-6000
CY2018Q1 us-gaap Increase Decrease In Other Noncurrent Liabilities
IncreaseDecreaseInOtherNoncurrentLiabilities
-3000
CY2019Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
9788000
CY2018Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
1572000
CY2019Q1 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
5437000
CY2019Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2088000
CY2018Q1 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1564000
CY2019Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3828000
CY2018Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-1564000
CY2019Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
44000
CY2018Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
5185000
CY2018Q1 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
344000
CY2018Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-224000
CY2019Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
44000
CY2018Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
333000
CY2019Q1 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-3691000
CY2019Q1 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
12584000
CY2018Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
12141000
CY2019Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2313000
CY2018Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
117000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
193822000
CY2017Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
173759000
CY2019Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
196135000
CY2018Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
173876000
CY2019Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1055000
CY2018Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
937000
CY2018Q4 us-gaap Goodwill
Goodwill
326735000
CY2019Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
340000
CY2019Q1 us-gaap Goodwill
Goodwill
326395000
CY2019Q1 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
158581000
CY2019Q1 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
25933000
CY2019Q1 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
157881000
CY2019Q1 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P16Y
CY2018Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
23498000
CY2018Q4 us-gaap Intangible Assets Gross Excluding Goodwill
IntangibleAssetsGrossExcludingGoodwill
158936000
CY2018 us-gaap Finite Lived Intangible Asset Useful Life
FiniteLivedIntangibleAssetUsefulLife
P16Y
CY2018Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
158236000
CY2019Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
7851000
CY2019Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
9930000
CY2019Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
9453000
CY2019Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
9450000
CY2019Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
9451000
CY2019Q1 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
26899000
CY2018Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
24937000
CY2019Q1 us-gaap Inventory Net
InventoryNet
44920000
CY2018Q4 us-gaap Inventory Net
InventoryNet
42263000
CY2017 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2018 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2019Q1 rgen Tax Cuts And Jobs Act Of2017 Incomplete Accounting Change In Tax Rate Deferred Tax Liability Provisional Income Tax Benefit
TaxCutsAndJobsActOf2017IncompleteAccountingChangeInTaxRateDeferredTaxLiabilityProvisionalIncomeTaxBenefit
12800000
CY2017 rgen Tax Cuts And Jobs Act Of2017 Incomplete Accounting Transition Tax For Accumulated Foreign Earnings Provisional Income Tax Expense
TaxCutsAndJobsActOf2017IncompleteAccountingTransitionTaxForAccumulatedForeignEarningsProvisionalIncomeTaxExpense
3300000
CY2019Q1 us-gaap Net Income Loss
NetIncomeLoss
8053000
CY2018Q1 us-gaap Net Income Loss
NetIncomeLoss
3448000
CY2019Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43968
CY2018Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
43621
CY2019Q1 us-gaap Liabilities
Liabilities
172896000
CY2018Q4 us-gaap Liabilities
Liabilities
159053000
CY2018Q4 us-gaap Unbilled Receivables Current
UnbilledReceivablesCurrent
2602000
CY2019Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
60634000
CY2018Q1 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
44830000
CY2019Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-655000
CY2018Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1400000
CY2019Q1 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
-1891000
CY2018Q1 us-gaap Accumulated Other Comprehensive Income Loss Foreign Currency Translation Adjustment Net Of Tax
AccumulatedOtherComprehensiveIncomeLossForeignCurrencyTranslationAdjustmentNetOfTax
251000
CY2018Q1 us-gaap New Accounting Pronouncement Or Change In Accounting Principle Cumulative Effect Of Change On Equity Or Net Assets1
NewAccountingPronouncementOrChangeInAccountingPrincipleCumulativeEffectOfChangeOnEquityOrNetAssets1
-677000
CY2018Q1 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-1000
CY2019Q1 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
39341000
CY2019Q1 us-gaap Deferred Revenue
DeferredRevenue
1287000
CY2018Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
878000
CY2019Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
132648000
CY2018Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
135438000
CY2018Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2700000
CY2019Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
2600000
CY2019Q1 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
85813000
CY2019Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
131948000
CY2019Q1 us-gaap Land
Land
1023000
CY2019Q1 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
764000
CY2019Q1 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
22782000
CY2018Q4 us-gaap Leasehold Improvements Gross
LeaseholdImprovementsGross
16259000
CY2019Q1 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
26332000
CY2018Q4 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
24092000
CY2019Q1 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
6362000
CY2018Q4 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
5448000
CY2019Q1 us-gaap Construction In Progress Gross
ConstructionInProgressGross
6826000
CY2018Q4 us-gaap Construction In Progress Gross
ConstructionInProgressGross
12906000
CY2019Q1 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
64139000
CY2018Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
60492000
CY2019Q1 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
29613000
CY2018Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
28312000
CY2018Q4 us-gaap Land
Land
1023000
CY2018Q4 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
764000
CY2019Q1 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
6329000
CY2018Q4 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
9953000
CY2019Q1 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1155000
CY2018Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
1024000
CY2019Q1 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
645000
CY2018Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
242000
CY2019Q1 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
527000
CY2018Q4 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
683000
CY2019Q1 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
941000
CY2018Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
942000
CY2019Q1 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1287000
CY2018Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
1290000
CY2019Q1 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1276000
CY2018Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
1185000
CY2019Q1 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
600000
CY2018Q4 us-gaap Product Warranty Accrual Classified Current
ProductWarrantyAccrualClassifiedCurrent
546000
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
998226
CY2018Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
27.54
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
31498
CY2019Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
59.52
CY2019Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1893
CY2019Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
22.35
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
0
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1027831
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
28.53
CY2019Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y14D
CY2019Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y6M14D
CY2019Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y11M15D
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
31469000
CY2019Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
20231000
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
30511000
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
540600
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
21.66
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
985138
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
100000
CY2018Q1 us-gaap Depreciation
Depreciation
1300000
CY2019Q1 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
226000
CY2019Q1 us-gaap Payments To Acquire Software
PaymentsToAcquireSoftware
1740000
CY2019Q1 us-gaap Depreciation
Depreciation
1600000
CY2018Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
227000
CY2019Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
200000
CY2019Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
30.21
CY2018Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
18.27
CY2019Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
2200000
CY2018Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
1300000
CY2019Q1 us-gaap Share Price
SharePrice
59.08
CY2019Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P4Y3M14D
CY2019Q1 rgen Sharebased Compensation Arrangement By Sharebased Payment Award Options And Equity Instruments Other Than Options Nonvested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsAndEquityInstrumentsOtherThanOptionsNonvestedNumberOfShares
1067389
CY2019Q1 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
33200000
CY2018Q1 rgen Lease Agreement Area
LeaseAgreementArea
63761
CY2019Q1 rgen Lease Agreement Area
LeaseAgreementArea
45000
CY2019Q1 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
725
CY2018Q1 us-gaap Weighted Average Number Of Shares Restricted Stock
WeightedAverageNumberOfSharesRestrictedStock
390
CY2019Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
1586
CY2018Q1 us-gaap Incremental Common Shares Attributable To Conversion Of Debt Securities
IncrementalCommonSharesAttributableToConversionOfDebtSecurities
316
CY2019Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
2311
CY2018Q1 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
706
CY2019Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
46279
CY2018Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
44327
CY2019Q1 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
3917000
CY2018Q4 us-gaap Deferred Tax Assets Liabilities Net Noncurrent
DeferredTaxAssetsLiabilitiesNetNoncurrent
4355000
CY2019Q1 us-gaap Increase Decrease In Contract With Customer Asset
IncreaseDecreaseInContractWithCustomerAsset
-2602000
CY2018Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.01
CY2019Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2018Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2019Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2018Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2019Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2018Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2019Q1 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2019Q1 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000
CY2018Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2018Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000
CY2019Q1 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
44073998
CY2019Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
44073998
CY2018Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
43917378
CY2018Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
43917378
CY2018Q1 us-gaap Repayments Of Convertible Debt
RepaymentsOfConvertibleDebt
11000
CY2018Q1 us-gaap New Accounting Pronouncement Or Change In Accounting Principle Effect Of Adoption Quantification
NewAccountingPronouncementOrChangeInAccountingPrincipleEffectOfAdoptionQuantification
5609000
CY2018Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
593874
CY2018Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.247
CY2019Q1 rgen Impairment Loss On Receivables
ImpairmentLossOnReceivables
0
CY2019Q1 rgen Number Of Buildings Leased
NumberOfBuildingsLeased
4
CY2019Q1 us-gaap Contract With Customer Performance Obligation Satisfied In Previous Period
ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod
CY2019Q1 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
16185000
CY2019Q1 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3100000
CY2019Q1 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
17088000
CY2019Q1 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
104595000
CY2018Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
103488000
CY2018Q4 us-gaap Deferred Rent Credit
DeferredRentCredit
4000000
CY2019Q1 us-gaap Property Plant And Equipment Other
PropertyPlantAndEquipmentOther
50000
CY2018Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35
CY2019Q1 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.21
CY2019Q1 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
210388
CY2019Q1 rgen Increase Decrease In Revenue From Contract With Customer
IncreaseDecreaseInRevenueFromContractWithCustomer
15813000
CY2019Q1 rgen Percentage Of Incraese Decrease In Revenue From Contract With Customer
PercentageOfIncraeseDecreaseInRevenueFromContractWithCustomer
0.353
CY2019Q1 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P7Y4M20D
CY2019Q1 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.0462
CY2019Q1 rgen Increase Decrease In Sales Revenue Goods Net
IncreaseDecreaseInSalesRevenueGoodsNet
15813000
CY2019Q1 rgen Percentage Change In Sales Revenue Goods Net
PercentageChangeInSalesRevenueGoodsNet
35.3
CY2019Q1 rgen Increase Decrease In Royalty Revenue
IncreaseDecreaseInRoyaltyRevenue
-9000
CY2019Q1 rgen Percentage Change In Royalty Revenue
PercentageChangeInRoyaltyRevenue
-29.0
CY2019Q1 rgen Increase Decrease In Revenues
IncreaseDecreaseInRevenues
15804000
CY2019Q1 rgen Percentage Change In Revenue
PercentageChangeInRevenue
35.3
CY2019Q1 dei Document Type
DocumentType
10-Q
CY2019Q1 dei Amendment Flag
AmendmentFlag
false
CY2019Q1 dei Document Period End Date
DocumentPeriodEndDate
2019-03-31
CY2019Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2019
CY2019Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2019Q1 dei Entity Registrant Name
EntityRegistrantName
REPLIGEN CORP
CY2019Q1 dei Entity Central Index Key
EntityCentralIndexKey
0000730272
CY2019Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2019Q1 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2019Q1 dei Trading Symbol
TradingSymbol
RGEN
CY2019Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2019Q1 dei Entity Small Business
EntitySmallBusiness
false
CY2019Q2 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
47225369
CY2018Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
134738000
CY2014Q1 rgen Lease Commencement Date
LeaseCommencementDate
2014-08-01
CY2014Q1 rgen Lease Agreement Term
LeaseAgreementTerm
P8Y
CY2019Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.234
CY2019Q1 us-gaap Basis Of Accounting
BasisOfAccounting
<table cellpadding="0" cellspacing="0" style="font-family: &quot;times new roman&quot;; font-size: 10pt; border-spacing: 0px; margin-bottom: 0px; margin-top: 0px; table-layout: fixed;;text-align:left;;width:100%;"><tr style="vertical-align: top;"><td style="overflow-wrap: break-word; vertical-align: top; width: 0in; padding: 0px;"></td><td style="overflow-wrap: break-word; vertical-align: top; width: 0.79in;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-left: 0in; text-indent: 0in; background: none; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">1.</div></div><div style="font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> </div></div></td><td style="overflow-wrap: break-word; vertical-align: top;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-left: 0in; text-indent: 0in; background: none; line-height: normal;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Basis of Presentation </div></div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px;"></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-left: 0.79in; margin-top: 6pt; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The consolidated financial statements included herein have been prepared by Repligen Corporation (the &#8220;Company&#8221;, &#8220;Repligen&#8221; or &#8220;we&#8221;) in accordance with generally accepted accounting principles in the United States (&#8220;GAAP&#8221;) and pursuant to the rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;), for Quarterly Reports on Form 10-Q and Article 10 of Regulation S-X and do not include all of the information and footnote disclosures required by GAAP. These consolidated financial statements should be read in conjunction with the audited consolidated financial statements and accompanying notes thereto included in the Company&#8217;s Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2018. </div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-left: 0.79in; margin-top: 6pt; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. </div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-left: 0.79in; margin-top: 6pt; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Repligen Sweden AB, Repligen GmbH, Spectrum LifeSciences, LLC and its subsidiaries (&#8220;Spectrum,&#8221; acquired on August&#160;1, 2017) and Repligen Singapore Pte. Ltd. All significant intercompany accounts and transactions have been eliminated in consolidation.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-left: 0.79in; margin-top: 6pt; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In the opinion of management, the accompanying unaudited consolidated financial statements include all adjustments, consisting of only normal, recurring adjustments necessary for a fair presentation of the financial position, results of operations and cash flows. The results of operations for the interim periods presented are not necessarily indicative of results to be expected for the entire year. </div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-left: 0.79in; margin-top: 18pt; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;"><div style="font-weight:bold;display:inline;">Recent Accounting Standards Updates </div></div></div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-left: 0.79in; margin-top: 6pt; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">We consider the applicability and impact of all Accounting Standards Updates on our consolidated financial statements. Updates not listed below were assessed and determined to be either not applicable or are expected to have minimal impact on our consolidated financial position or results of operations. Recently issued Accounting Standards Updates which we feel may be applicable to us are as follows: </div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-left: 0.79in; margin-top: 18pt; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Recently Issued Accounting Standard Updates &#8211; Not Yet Adopted </div></div></div><div style="font-family: &quot;times new roman&quot;, serif; margin-bottom: 0px; margin-left: 0.79in; margin-top: 6pt; background: none; font-size: 10pt;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In August 2018, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued Accounting Standards Update No. (&#8220;ASU&#8221;) 2018-13, </div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">&#8220;Fair Value Measurement (Topic 820): Disclosure Framework &#8211; Changes to the Disclosure Requirements for Fair Value Measurement.&#8221; </div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">ASU 2018-13 includes amendments that aim to improve the effectiveness of fair value measurement disclosures. The amendments in this guidance modify the disclosure requirements on fair value measurements based on the concepts in FASB Concepts Statement, </div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">&#8220;Conceptual Framework for Financial Reporting&#8212;Chapter 8: Notes to Financial Statements</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">,</div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">&#8221;</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> including the consideration of costs and benefits. The amendments become effective for the Company in the year ending December&#160;31, 2020 and early adoption is permitted. The Company is currently assessing the impact that this guidance will have on its consolidated financial statements.</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-left: 0.79in; margin-top: 6pt; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In August 2018, the FASB issued ASU 2018-15, </div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">&#8220;Intangibles &#8211; Goodwill and Other &#8211; Internal-Use Software (Subtopic 350-40): Customer&#8217;s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract.&#8221; </div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">ASU 2018-15 aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal-use software license). The guidance also requires the entity to expense the capitalized implementation costs of a hosting arrangement that is a service contract over the term of the hosting arrangement, which includes reasonably certain renewals. The guidance becomes effective for the Company in the year ending December&#160;31, 2020 and early adoption is permitted. The Company is currently assessing the impact that this guidance will have on its consolidated financial statements. </div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-left: 0.79in; margin-top: 6pt; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In November 2018, the FASB issued ASU 2018-18, </div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">&#8220;Collaborative Arrangements (Topic 808): Clarifying the Interaction between Topic 808 and Topic 606.&#8221; </div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">ASU 2018-18 clarifies the interaction between Topic 808, </div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">&#8220;Collaborative Arrangements,&#8221; </div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">and Topic 606, </div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">&#8220;Revenue from Contracts with Customers,&#8221; </div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">by making targeted improvements to GAAP for collaborative arrangements and providing guidance on whether certain transactions between collaborative arrangement participants should be accounted for with revenue under Topic 606. This includes improving comparability in the presentation of revenue for certain transactions between collaborative arrangement participants by allowing presentation of the units of account in collaborative arrangements that are within the scope of Topic 606 together with revenue accounted for under Topic 606. The guidance becomes effective for the Company in the year ending December&#160;31, 2020 and early adoption is permitted. The Company is currently assessing the impact that this guidance will have on its consolidated financial statements. </div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-left: 0.79in; margin-top: 18pt; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Recently Issued Accounting Standard Updates &#8211; Adopted During the Period </div></div></div><div style="font-family: &quot;times new roman&quot;, serif; margin-bottom: 0px; margin-left: 0.79in; margin-top: 6pt; background: none; font-size: 10pt;">In February 2016, the FASB issued ASU 2016-02,<div style="font-style:italic;display:inline;;font-style:italic;display:inline;">&#160;&#8220;Leases (Topic 842).&#8221;</div>ASU 2016-02, along with subsequent ASUs issued to clarify certain provisions of ASU 2016-02 (collectively known as &#8220;ASC 842&#8221;), establishes a right-of-use (&#8220;ROU&#8221;) model that requires a lessee to record a ROU asset and a lease liability on the consolidated balance sheet for all leases with terms longer than 12 months. Certain qualitative and quantitative disclosures are also required. The Company adopted ASU 2016-02 and related amendments on January&#160;1, 2019 using an optional transition method allowed with the issuance of ASU 2018-11, <div style="font-style:italic;display:inline;;font-style:italic;display:inline;">&#8220;Leases &#8211; Targeted Improvements (Topic 842),&#8221;</div> in July 2018. ASU 2018-11 gives entities the option to not provide comparative period financial statements and instead apply the transition requirements as of the effective date of the new standard. Pursuant to additional guidance under ASC 842, the Company also elected the optional package of practical expedients, which allowed the Company to not reassess: (i)&#160;whether expired or existing contracts contain leases; (ii)&#160;lease classification for any expired or existing leases; and (iii)&#160;initial direct costs for any existing leases. As a result, the consolidated balance sheet prior to January&#160;1, 2019 was not restated, continues to be reported under ASC 840, <div style="font-style:italic;display:inline;;font-style:italic;display:inline;">&#8220;Leases&#8221;,</div> which did not require the recognition of operating lease liabilities on the consolidated balance sheet, and is not comparative. Under ASC 842, all leases are required to be recorded on the balance sheet and are classified as either operating leases or finance leases, which is determined at the inception of the lease. The lease classification affects the expense recognition in the consolidated statements of comprehensive income. The expense recognition for operating leases and finance leases under ASC 842 is substantially consistent with ASC 840. Therefore, there is no significant difference in our results of operations presented in our consolidated statements of comprehensive income for each period presented. The Company also elected under the package of practical expedients, to combine lease and non-lease components and not to record leases with an initial term of 12 months or less on the balance sheet. The Company adopted ASC 842 using the optional transition method for all leases existing at January&#160;1, 2019. The adoption had a substantial impact on our balance sheet. The most significant impact was the recognition of the operating lease ROU assets and lease liabilities for operating leases. Upon adoption, leases that were classified as operating leases under ASC 840 were classified as operating leases under ASC 842, and we recorded ROU assets of<div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> $17.0&#160;million and lease liabilities of $21.0&#160;million, before considering deferred taxes. The lease liability is based on the present value of the remaining minimum lease payments, determined under ASC 840, discounted using our incremental borrowing rate at the effective date January&#160;1, 2019. The difference between the ROU assets and the lease liabilities is due to approximately $4&#160;million of unamortized lease incentives and deferred rent at the Company&#8217;s </div>Marlborough and Waltham facilities as of December&#160;31, 2018. There was no impact to our beginning retained earnings upon adoption of ASC 842. See Note 4,&#160;<div style="/* color: rgb(0, 0, 0); */font-family: 'times new roman';font-size: 13.3333px;font-variant-ligatures: normal;font-variant-caps: normal;font-weight: 400;letter-spacing: normal;orphans: 2;text-align: start;text-indent: 0px;text-transform: none;white-space: normal;widows: 2;word-spacing: 0px;-webkit-text-stroke-width: 0px;/* background-color: rgb(255, 255, 255); */text-decoration-style: initial;text-decoration-color: initial;;font-style:italic;display:inline;;font-style:italic;display:inline;">&#8220;Leases,&#8221;&#160;</div>below for more information on the Company&#8217;s adoption of ASC 842.</div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; margin-bottom: 0px; margin-left: 0.79in; margin-top: 6pt; background: none;"><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;">In February 2018, the FASB issued ASU 2018-02, </div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">&#8220;Income Statement &#8211; Reporting Comprehensive Income (Topic 220): Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income,&#8221;</div></div><div style="font-family: &quot;times new roman&quot;, serif; font-size: 10pt; background: none; color: rgb(0, 0, 0); letter-spacing: 0px; top: 0px;;display:inline;"> which gives entities the option to reclassify to retained earnings tax effects related to items that have been stranded in accumulated other comprehensive income as a result of the Tax Cuts and Jobs Act (the &#8220;Act&#8221;). Entities can choose whether to apply the amendments retrospectively to each period in which the effect of the Act is recognized or to apply the amendments in the period of adoption. This guidance became effective for the Company in the first quarter of 2019 and had no impact on our consolidated financial statements. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
4021000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
3599000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
3263000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
2213000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1316000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due Thereafter
OperatingLeasesFutureMinimumPaymentsDueThereafter
3622000
CY2019Q1 us-gaap Operating Lease Payments
OperatingLeasePayments
985000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Remainder Of Fiscal Year
LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear
2949000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
4035000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
3938000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
3006000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
2038000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
8332000
CY2019Q1 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
24298000
CY2019Q1 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
4110000
CY2019Q1 us-gaap Operating Lease Liability
OperatingLeaseLiability
20188000
CY2019Q1 us-gaap Business Acquisition Cost Of Acquired Entity Transaction Costs
BusinessAcquisitionCostOfAcquiredEntityTransactionCosts
1000000
CY2019Q1 us-gaap Business Combination Separately Recognized Transactions Additional Disclosures Acquisition Cost Expensed
BusinessCombinationSeparatelyRecognizedTransactionsAdditionalDisclosuresAcquisitionCostExpensed
500000
CY2019Q1 us-gaap Operating Lease Cost
OperatingLeaseCost
930000
CY2019Q1 rgen Variable Operating Lease Cost
VariableOperatingLeaseCost
281000
CY2019Q1 us-gaap Lease Cost
LeaseCost
1211000
CY2019Q1 rgen Indefinite Lived Intangible Assets Accumulated Amortization
IndefiniteLivedIntangibleAssetsAccumulatedAmortization
-25933000
CY2018Q4 rgen Indefinite Lived Intangible Assets Accumulated Amortization
IndefiniteLivedIntangibleAssetsAccumulatedAmortization
-23498000
CY2017 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
five-year options to extend through July 2035
CY2019Q1 us-gaap Lessee Operating Lease Lease Not Yet Commenced Option To Extend
LesseeOperatingLeaseLeaseNotYetCommencedOptionToExtend
Excludes approximately $6&#160;million associated with two of the three 5-year renewal options for the Rancho Dominguez original lease since the renewal options have not been executed
CY2019Q1 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
131948000
CY2018Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
18034000
CY2019Q1 rgen Increasedecrease In Operating Lease Right Of Use Asset
IncreasedecreaseInOperatingLeaseRightOfUseAsset
-784000
CY2019Q1 rgen Increasedecrease In Operating Lease Liability
IncreasedecreaseInOperatingLeaseLiability
-840000

Files In Submission

Name View Source Status
0001193125-19-142798-index-headers.html Edgar Link pending
0001193125-19-142798-index.html Edgar Link pending
0001193125-19-142798.txt Edgar Link pending
0001193125-19-142798-xbrl.zip Edgar Link pending
d674094d10q.htm Edgar Link pending
d674094dex311.htm Edgar Link pending
d674094dex312.htm Edgar Link pending
d674094dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R75.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rgen-20190331.xml Edgar Link completed
rgen-20190331.xsd Edgar Link pending
rgen-20190331_cal.xml Edgar Link unprocessable
rgen-20190331_def.xml Edgar Link unprocessable
rgen-20190331_lab.xml Edgar Link unprocessable
rgen-20190331_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending